<i>Candidozyma auris</i> susceptibility from Michigan hospitals to manogepix, rezafungin and nine other antifungal agents. [PDF]
Klamer KS +4 more
europepmc +1 more source
Comprehensive strategies to defeat Candida auris - challenge and insight: A review. [PDF]
Zhang J +6 more
europepmc +1 more source
Old and new strategies in therapy and diagnosis against fungal infections. [PDF]
Vanzolini T, Magnani M.
europepmc +1 more source
Next-generation antifungal drugs: Mechanisms, efficacy, and clinical prospects. [PDF]
Lu X +9 more
europepmc +1 more source
Refractory <i>Candidozyma</i> (<i>Candida</i>) <i>auris</i>-associated central nervous system infection in a postoperative neurosurgical patient. [PDF]
Xue YC, Thomas K, Zaidan N, Ren P.
europepmc +1 more source
Successful treatment of a resistant invasive disseminated Fusarium infection in an immunocompetent patient. [PDF]
Frantzeskaki F +5 more
europepmc +1 more source
Invasive Fungal Sinusitis in Patients With Hematological Malignancies: A 20-Year Study From a Tertiary Academic US Hospital System. [PDF]
Athni TS +12 more
europepmc +1 more source
Bridging the Gap between Sequence and Structure Classifications of Proteins with AlphaFold Models. [PDF]
Pei J +8 more
europepmc +1 more source
When Should Clinical Mycology Laboratories Perform Antifungal Susceptibility Testing? Revisiting Practice Through the Lens of Intrinsic Resistance. [PDF]
Lass-Flörl C, Arikan-Akdagli S.
europepmc +1 more source

